Effect of insulin analogues on phosphatidyl inositol-3 kinase/Akt signalling in INS-1 rat pancreatic derived β-cells

References

• Agin A, Jeandidier N, Gasser F, et al. (2007). Glargine blood biotransformation: In vitro appraisal with human insulin immunoassay. Diabetes Metab, 33:205–12
   PubMed Web of Science ®Google Scholar
• Allen TR, Krueger KD, Hunter 3rd WJ, Agrawal DK. (2005). Evidence that insulin-like growth factor-1 requires protein kinase C-epsilon, PI3-kinase and mitogen-activated protein kinase pathways to protect human vascular smooth muscle cells from apoptosis. Immunol Cell Biol, 83:651–67
   PubMed Web of Science ®Google Scholar
• Angers S, Salahpour A, Joly E, et al. (2000). Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc Natl Acad Sci USA, 97:3684–9
   PubMed Web of Science ®Google Scholar
• Bahr M, Kolter T, Seipke G, Eckel J. (1997). Growth promoting and metabolic activity of the human insulin analogue [GlyA21,ArgB31,ArgB32]insulin (HOE 901) in muscle cells. Eur J Pharmacol, 320:259–65
   PubMed Web of Science ®Google Scholar
• Bailyes EM, Nave BT, Soos MA, et al. (1997). Insulin receptor/IGF-I receptor hybrids are widely distributed in mammalian tissues: Quantification of individual receptor species by selective immunoprecipitation and immunoblotting. Biochem J, 327:209–15
   PubMed Web of Science ®Google Scholar
• Baus D, Heermeier K, De Hoop M, et al. (2008). Identification of a novel AS160 splice variant that regulates GLUT4 translocation and glucose-uptake in rat muscle cells. Cell Signal, 20:2237–46
   PubMed Web of Science ®Google Scholar
• Berti L, Kellerer M, Bossenmaier B, et al. (1998). The long acting human insulin analog HOE 901: Characteristics of insulin signalling in comparison to Asp(B10) and regular insulin. Horm Metab Res, 30:123–9
   PubMed Web of Science ®Google Scholar
• Blanquart C, Achi J, Issad T. (2008). Characterization of IRA/IRB hybrid insulin receptors using bioluminescence resonance energy transfer. Biochem Pharmacol, 76:873–83
   PubMed Web of Science ®Google Scholar
• Blanquart C, Gonzalez-Yanes C, Issad T. (2006). Monitoring the activation state of insulin/insulin-like growth factor-1 hybrid receptors using bioluminescence resonance energy transfer. Mol Pharmacol, 70:1802–11
   PubMed Web of Science ®Google Scholar
• Bolli GB, Hahn AD, Schmidt R, et al. (2012). Plasma exposure to insulin glargine and its metabolites M1 and M2 after subcutaneous injection of therapeutic and supratherapeutic doses of glargine in subjects with type 1 diabetes. Diabetes Care, 35:2626–30
   PubMed Web of Science ®Google Scholar
• Boute N, Boubekeur S, Lacasa D, Issad T. (2003). Dynamics of the interaction between the insulin receptor and protein tyrosine-phosphatase 1B in living cells. EMBO Rep, 4:313–19
   PubMed Web of Science ®Google Scholar
• Boute N, Pernet K, Issad T. (2001). Monitoring the activation state of the insulin receptor using bioluminescence resonance energy transfer. Mol Pharmacol, 60:640–5
   PubMed Web of Science ®Google Scholar
• Burks DJ, White MF. (2001). IRS proteins and beta-cell function. Diabetes, 50:S140–5
   PubMed Web of Science ®Google Scholar
• Ciaraldi TP, Carter L, Seipke G, et al. (2001). Effects of the long-acting insulin analog insulin glargine on cultured human skeletal muscle cells: Comparisons to insulin and IGF-I. J Clin Endocrinol Metab, 86:5838–47
   PubMed Web of Science ®Google Scholar
• Combettes-Souverain M, Issad T. (1998). Molecular basis of insulin action. Diabetes Metab, 24:477–89
   PubMed Web of Science ®Google Scholar
• Cross TG, Scheel-Toellner D, Henriquez NV, et al. (2000). Serine/threonine protein kinases and apoptosis. Exp Cell Res, 256:34–41
   PubMed Web of Science ®Google Scholar
• Eckardt K, May C, Koenen M, Eckel J. (2007). IGF-1 receptor signalling determines the mitogenic potency of insulin analogues in human smooth muscle cells and fibroblasts. Diabetologia, 50:2534–43
   PubMed Web of Science ®Google Scholar
• Fardini Y, Masson E, Boudah O, et al. (2014). O-GlcNAcylation of FoxO1 in pancreatic beta cells promotes Akt inhibition through an IGFBP1-mediated autocrine mechanism. FASEB J, 28:1010–21
   PubMed Web of Science ®Google Scholar
• Federici M, Porzio O, Zucaro L, et al. (1997). Distribution of insulin/insulin-like growth factor-I hybrid receptors in human tissues. Mol Cell Endocrinol, 129:121–6
   PubMed Web of Science ®Google Scholar
• Federici M, Zucaro L, Porzio O, et al. (1996). Increased expression of insulin/insulin-like growth factor-I hybrid receptors in skeletal muscle of noninsulin-dependent diabetes mellitus subjects. J Clin Invest, 98:2887–93
   PubMed Web of Science ®Google Scholar
• Gerich JE. (2002). Novel insulins: Expanding options in diabetes management. Am J Med, 113:308–16
   PubMed Web of Science ®Google Scholar
• Heller S, Kozlovski P, Kurtzhals P. (2007). Insulin's 85th anniversary – An enduring medical miracle. Diabetes Res Clin Pract, 78:149–58
   PubMed Web of Science ®Google Scholar
• Hill MM, Andjelkovic M, Brazil DP, et al. (2001). Insulin-stimulated protein kinase B phosphorylation on Ser-473 is independent of its activity and occurs through a staurosporine-insensitive kinase. J Biol Chem, 276:25643–6
   PubMed Web of Science ®Google Scholar
• Hohmeier HE, Mulder H, Chen G, et al. (2000). Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion. Diabetes, 49:424–30
   PubMed Web of Science ®Google Scholar
• Issad T, Boute N, Boubekeur S, et al. (2003). Looking for an insulin pill? Use the BRET methodology! Diabetes Metab, 29:111–17
   PubMed Web of Science ®Google Scholar
• Issad T, Combettes M, Ferre P. (1995). Isoproterenol inhibits insulin-stimulated tyrosine phosphorylation of the insulin receptor without increasing its serine/threonine phosphorylation. Eur J Biochem, 234:108–15
   PubMedGoogle Scholar
• Kanwal S, Fardini Y, Pagesy P, et al. (2013). O-GlcNAcylation-inducing treatments inhibit estrogen receptor α expression and confer resistance to 4-OH-Tamoxifen in human breast cancer-derived MCF-7 cells. PLoS One, 8:9539–44
   Web of Science ®Google Scholar
• Kuerzel GU, Shukla U, Scholtz HE, et al. (2003). Biotransformation of insulin glargine after subcutaneous injection in healthy subjects. Curr Med Res Opin, 19:34–40
   PubMed Web of Science ®Google Scholar
• Kuo MS, Auriau J, Pierre-Eugene C, Issad T. (2014). Development of a human breast-cancer derived cell line stably expressing a bioluminescence resonance energy transfer (BRET)-based phosphatidyl inositol-3 phosphate (PIP3) biosensor. PLoS One, 9:e92737
   PubMed Web of Science ®Google Scholar
• Kurtzhals P, Schaffer L, Sorensen A, et al. (2000). Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes, 49:999–1005
   PubMed Web of Science ®Google Scholar
• Lacasa D, Boute N, Issad T. (2005). Interaction of the insulin receptor with the receptor-like protein tyrosine phosphatases PTPalpha and PTPepsilon in living cells. Mol Pharmacol, 67:1206–13
   PubMed Web of Science ®Google Scholar
• Leibiger IB, Brismar K, Berggren PO. (2010). Novel aspects on pancreatic beta-cell signal-transduction. Biochem Biophys Res Commun, 396:111–15
   PubMed Web of Science ®Google Scholar
• Liu JF, Issad T, Chevet E, et al. (1998). Fibroblast growth factor-2 has opposite effects on human breast cancer MCF-7 cell growth depending on the activation level of the mitogen-activated protein kinase pathway. Eur J Biochem, 258:271–6
   PubMedGoogle Scholar
• Merglen A, Theander S, Rubi B, et al. (2004). Glucose sensitivity and metabolism-secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells. Endocrinology, 145:667–78
   PubMed Web of Science ®Google Scholar
• Nouaille S, Blanquart C, Zilberfarb V, et al. (2006). Interaction with Grb14 results in site-specific regulation of tyrosine phosphorylation of the insulin receptor. EMBO Rep, 7:512–18
   PubMed Web of Science ®Google Scholar
• Pandini G, Vigneri R, Costantino A, et al. (1999). Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: Evidence for a second mechanism of IGF-I signaling. Clin Cancer Res, 5:1935–44
   PubMed Web of Science ®Google Scholar
• Pierre-Eugene C, Pagesy P, Nguyen TT, et al. (2012). Effect of insulin analogues on insulin/IGF1 hybrid receptors: Increased activation by glargine but not by its metabolites M1 and M2. PLoS One, 7:e41992
   PubMed Web of Science ®Google Scholar
• Rakatzi I, Ramrath S, Ledwig D, et al. (2003a). A novel insulin analog with unique properties: LysB3,GluB29 insulin induces prominent activation of insulin receptor substrate 2, but marginal phosphorylation of insulin receptor substrate 1. Diabetes, 52:2227–38
   PubMed Web of Science ®Google Scholar
• Rakatzi I, Seipke G, Eckel J. (2003b). [LysB3, GluB29] insulin: A novel insulin analog with enhanced beta-cell protective action. Biochem Biophys Res Commun, 310:852–9
   PubMed Web of Science ®Google Scholar
• Sciacca L, Cassarino MF, Genua M, et al. (2010). Insulin analogues differently activate insulin receptor isoforms and post-receptor signalling. Diabetologia, 53:1743–53
   PubMed Web of Science ®Google Scholar
• Shukla A, Grisouard J, Ehemann V, et al. (2009). Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines. Endocr Relat Cancer, 16:429–41
   PubMed Web of Science ®Google Scholar
• Sommerfeld MR, Muller G, Tschank G, et al. (2010). In vitro metabolic and mitogenic signaling of insulin glargine and its metabolites. PLoS One, 5:e9540
   PubMed Web of Science ®Google Scholar
• Soos MA, O'Brien RM, Brindle NP, et al. (1989). Monoclonal antibodies to the insulin receptor mimic metabolic effects of insulin but do not stimulate receptor autophosphorylation in transfected NIH 3T3 fibroblasts. Proc Natl Acad Sci USA, 86:5217–21
   PubMed Web of Science ®Google Scholar
• Soos MA, Whittaker J, Lammers R, et al. (1990). Receptors for insulin and insulin-like growth factor-I can form hybrid dimers. Characterisation of hybrid receptors in transfected cells. Biochem J, 270:383–90
   PubMed Web of Science ®Google Scholar
• Thevis M, Thomas A, Delahaut P, et al. (2005). Qualitative determination of synthetic analogues of insulin in human plasma by immunoaffinity purification and liquid chromatography–tandem mass spectrometry for doping control purposes. Anal Chem, 77):3579–85
   PubMed Web of Science ®Google Scholar
• Ueno H, Kondo E, Yamamoto-Honda R, et al. (2000). Association of insulin receptor substrate proteins with Bcl-2 and their effects on its phosphorylation and antiapoptotic function. Mol Biol Cell, 11:735–46
   PubMed Web of Science ®Google Scholar
• Vajo Z, Duckworth WC. (2000). Genetically engineered insulin analogs: Diabetes in the new millenium. Pharmacol Rev, 52:1–9
   PubMed Web of Science ®Google Scholar
• Werner U, Korn M, Schmidt R, et al. (2015). Metabolic effect and receptor signalling profile of a non-metabolisable insulin glargine analogue. Arch Physiol Biochem, 120:158–65
   Web of Science ®Google Scholar